1-2 of 2
Ritva Torma, RN
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Study of Suberoylanilide Hydroxamic Acid (SAHA) and Decitabine in Patients with Relapsed, Refractory or Poor Prognosis Leukemia.

Farhad Ravandi, MD, Stefan Faderl, MD, Deborah Thomas, MD, Jan Burger, MD, Charles Koller, MD, Guillermo Garcia-Manero, MD, Gail Morris, RN, Ritva Torma, RN, Hagop Kantarjian, MD, Jean-Pierre Issa, MD
Journal: Blood
Blood (2007) 110 (11): 897.
https://doi.org/10.1182/blood.V110.11.897.897
Published: 2007
Journal Articles

Report of a Phase1/2 Study of 5-Azacitidine and Cytarabine in Patients with Relapsed, Refractory Acute Myelogenous Leukemia.

Gautam Borthakur, MD, Hagop Kantarjian, MD, Susan O’Brien, MD, Farhad Ravandi, MD, Charles Koller, MD, Zeev Estrov, MD, Ritva Torma, RN, Jean-Pierre Issa, MD
Journal: Blood
Blood (2007) 110 (11): 911.
https://doi.org/10.1182/blood.V110.11.911.911
Published: 2007